PT975334E - Microparticulas biodegradaveis para a libertacao sustentada de farmacos terapeuticos - Google Patents

Microparticulas biodegradaveis para a libertacao sustentada de farmacos terapeuticos

Info

Publication number
PT975334E
PT975334E PT98918424T PT98918424T PT975334E PT 975334 E PT975334 E PT 975334E PT 98918424 T PT98918424 T PT 98918424T PT 98918424 T PT98918424 T PT 98918424T PT 975334 E PT975334 E PT 975334E
Authority
PT
Portugal
Prior art keywords
pharmacos
therapeutic
biodegradable microparticles
sustained
sustained liberation
Prior art date
Application number
PT98918424T
Other languages
English (en)
Inventor
Subodh Shah
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/843,975 external-priority patent/US6020004A/en
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of PT975334E publication Critical patent/PT975334E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
PT98918424T 1997-04-17 1998-04-17 Microparticulas biodegradaveis para a libertacao sustentada de farmacos terapeuticos PT975334E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/843,975 US6020004A (en) 1997-04-17 1997-04-17 Biodegradable microparticles for the sustained delivery of therapeutic drugs
US6166598A 1998-04-16 1998-04-16

Publications (1)

Publication Number Publication Date
PT975334E true PT975334E (pt) 2004-03-31

Family

ID=26741350

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98918424T PT975334E (pt) 1997-04-17 1998-04-17 Microparticulas biodegradaveis para a libertacao sustentada de farmacos terapeuticos

Country Status (10)

Country Link
EP (1) EP0975334B1 (pt)
JP (1) JP2002514215A (pt)
AT (1) ATE252375T1 (pt)
AU (1) AU7134898A (pt)
CA (1) CA2287534C (pt)
DE (1) DE69819145T2 (pt)
DK (1) DK0975334T3 (pt)
ES (1) ES2205481T3 (pt)
PT (1) PT975334E (pt)
WO (1) WO1998046212A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1074923C (zh) 1993-11-19 2001-11-21 詹森药业有限公司 微囊密封的3-哌啶基取代的1,2-苯并异唑类和1,2-苯并异噻唑类
US6291013B1 (en) 1999-05-03 2001-09-18 Southern Biosystems, Inc. Emulsion-based processes for making microparticles
AU1226901A (en) * 1999-10-22 2001-05-08 Amgen, Inc. Biodegradable microparticles with novel erythropoietin stimulating protein
JP2003519651A (ja) * 2000-01-14 2003-06-24 ブラウン ユニバーシティ リサーチ ファウンデーション 微紛化凍結乾燥粒子
US7029700B2 (en) 2000-01-14 2006-04-18 Brown University Research Foundation Micronized freeze-dried particles
AU2000202A (en) * 2000-10-31 2002-05-15 Pr Pharmaceuticals Inc Methods and compositions for enhanced delivery of bioactive molecules
DE60311801T2 (de) * 2002-05-02 2007-11-08 PR Pharmaceuticals, Inc., Fort Collins Zusammensetzungen aus östradiol-metaboliten mit kontrollierter freisetzung
EP1829529A1 (en) * 2002-05-03 2007-09-05 PR Pharmaceuticals, Inc. Controlled release compositions of estradiol metabolites
BRPI0409322B8 (pt) 2003-04-11 2021-05-25 Antriabio Inc método para preparar um conjugado de insulina-polímero
EP2335689A1 (en) 2004-05-12 2011-06-22 Baxter International Inc. Method of manufacturing nucleic acid micropheres
JP2007537288A (ja) 2004-05-12 2007-12-20 バクスター インターナショナル インコーポレイテッド オリゴヌクレオチド含有マイクロスフェア、１型糖尿病を処置する医薬の製造のための、その使用
EP1679065A1 (en) * 2005-01-07 2006-07-12 OctoPlus Sciences B.V. Controlled release compositions for interferon based on PEGT/PBT block copolymers
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
JP5118139B2 (ja) 2006-08-04 2013-01-16 バクスター・インターナショナル・インコーポレイテッド 新規発症自己免疫性糖尿病を予防および／または逆転させるためのマイクロスフィアに基づく組成物
JP5744513B2 (ja) 2007-04-17 2015-07-08 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 肺送達のための核酸微小粒子
US20110059167A1 (en) * 2008-05-06 2011-03-10 Glaxo Group Limited Encapsulation of biologically active agents
US20110311630A1 (en) * 2008-06-09 2011-12-22 Boehringer Ingelheim International Gmbh Novel embedment particles for inhalation
KR20100037389A (ko) * 2008-10-01 2010-04-09 연세대학교 산학협력단 다중 약물방출조절이 가능한 솔리드 마이크로구조체 및 이의 제조방법
JP2019528248A (ja) 2016-07-18 2019-10-10 ティシュージェン， インク． 生体分子の立体配座及び構造健全性を維持するための方法及び組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6058915A (ja) * 1983-09-12 1985-04-05 Fujisawa Pharmaceut Co Ltd 薬物含有脂質小胞体製剤
JP2653255B2 (ja) * 1990-02-13 1997-09-17 武田薬品工業株式会社 長期徐放型マイクロカプセル
WO1996022786A1 (en) * 1995-01-23 1996-08-01 Takeda Chemical Industries, Ltd. Sustained-release preparation and use

Also Published As

Publication number Publication date
JP2002514215A (ja) 2002-05-14
DE69819145D1 (de) 2003-11-27
CA2287534A1 (en) 1998-10-22
AU7134898A (en) 1998-11-11
WO1998046212A1 (en) 1998-10-22
ATE252375T1 (de) 2003-11-15
HK1022265A1 (en) 2000-08-04
EP0975334A1 (en) 2000-02-02
DE69819145T2 (de) 2004-08-19
DK0975334T3 (da) 2004-01-19
EP0975334B1 (en) 2003-10-22
ES2205481T3 (es) 2004-05-01
CA2287534C (en) 2004-12-28

Similar Documents

Publication Publication Date Title
PT975334E (pt) Microparticulas biodegradaveis para a libertacao sustentada de farmacos terapeuticos
ATE387430T1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
ATE324907T1 (de) Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen
EP1100522A4 (en) ADMINISTRATION OF ACTIVE AGENTS OVER THE LUNG
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
AU7315301A (en) Compounds and compositions for delivering active agents
IL140930A0 (en) Compounds and compositions for delivering active agents
BR9916053B1 (pt) composições contendo um peptìdeo e um ácido glicólico poliláctico, adequadas para preparação de implantes subcutáneos com perìodo de liberação prolongado.
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
DE69942154D1 (de) Medikamenthaltige zusammensetzung in aerosolform
BR0212921A (pt) Composição farmacêutica com base em fondant
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
NO20025621D0 (no) Farmasöytisk sammensetning med vedvarende frigjöring for parenteral administrasjon av hydrofile forbindelser
BR9810495A (pt) Composição farmacêutica
CY1111698T1 (el) Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
BR9811094A (pt) Agente terapêutico para tumores linfáticos
DE60024414T2 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
DK1228097T3 (da) Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge
MY140724A (en) Novel arylethene-sulfonamides
DK1189615T3 (da) Endoparasiticid synergistisk kombination indeholdende cykliske depsipeptider og piperaziner
ATE397447T1 (de) Feste paroxetin enthaltende zubereitungen
BR0202759A (pt) Composição farmacêutica de liberação modificada contendo bupropiona como substância ativa
DK0817643T3 (da) Forbindelser og præparater til administration af aktive midler
DE50311479D1 (de) Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung